Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. [electronic resource]
Producer: 20100812Description: 1199-204 p. digitalISSN:- 1532-0979
- Antibody Specificity
- Biomarkers, Tumor -- analysis
- Biopsy
- Brain Neoplasms -- enzymology
- Diagnosis, Differential
- Glioma -- enzymology
- Gliosis -- diagnosis
- Humans
- Immunohistochemistry
- Isocitrate Dehydrogenase -- analysis
- Mutation
- Neoplasm Staging
- Neuroglia -- enzymology
- Predictive Value of Tests
- Sensitivity and Specificity
- Treatment Outcome
- Tumor Suppressor Protein p53 -- analysis
- WT1 Proteins -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.